After a nearly unanimous vote in Parliament Tuesday to consider a change in the country’s drug policy, Lithuania looks poised to usher in medical marijuana. This potential lifeline for patients is headed for debate on Dec. 12, and if the latest show of support is any indication, the shift in attitude could lead to a new era of medicine for the country.
Cannabis is currently a List 1 Substance in Lithuania, alongside drugs like cocaine, heroin, methadone, morphine, and opium — narcotic drugs with “addictive properties, presenting a serious risk of abuse.” Tetrahydrocannabinol (THC) is listed as a psychotropic substance having “very little or no therapeutic value.” If this next step successfully advances marijuana as medicine, the country will be significantly closer to changing regulations to allow for the medical application of any “List 1 Substance,” provided there is scientific evidence to support its use.
Lithuania’s neighboring countries of Germany and Poland have changed their laws to allow for limited medical marijuana use.
In an effort to learn more about the situation, Marijuana.com contacted Member of Parliament Mykolas Majauskas, the…